Metastatic spinal cord compression

Implementing NICE guidance

2nd edition Oct 2011

NICE clinical guideline 75

NICE Pathway

The NICE metastatic spinal cord compression pathway covers

Click here to go to NICE Pathways

website

Related NICE guidance

• Improving outcomes for people with brain and other CNS tumours. NICE cancer service guidance (2006)

• Improving outcomes for people with sarcoma. NICE cancer service guidance (2006)

• Improving supportive and palliative care for adults with cancer. NICE cancer service guidance (2004)

What this presentation covers

Background

Key priorities for implementation

Costs and savings

Discussion

Find out more

Background

MSCC is a rare complication of cancer and is usually an oncological emergency

Some patients experience significant delays from the time when they first develop symptoms to referral

Nearly half of all patients with MSCC are unable to walk at the time of diagnosis

Early detection, treatment and care can reduce the risk of developing avoidable disability and premature death

Early surgery may be more effective than radiotherapy at maintaining mobility

Key priorities for implementation

• Service configuration and urgency of treatment• Early detection• Imaging• Treatment of spinal metastases and MSCC• Supportive care and rehabilitation

Every cancer network should ensure that appropriate services are commissioned and in place for the efficient and effective diagnosis, treatment, rehabilitation and ongoing care of patients with MSCC

These services should be monitored regularly through prospective audit of the care pathway

Service configuration and urgency of treatment

Inform patients with cancer who are at risk of MSCC information about the symptoms of MSCC and what to do and who to contact if those symptoms develop

Discuss with the MSCC coordinator

Early detection

• immediately patients with cancer who have symptoms of spinal metastases and neurological symptoms or signs suggestive of MSCC and view as an emergency

• within 24 hours patients with cancer who have symptoms suggestive of spinal metastases

It is important that MRI should be done quickly, dependent upon signs and symptoms

Imaging

Nurse flat with spine in neutral alignment patients with severe mechanical pain suggestive of

Treatment of spinal metastases and MSCC: 1

• spinal instability or

• neurological symptoms or

• signs suggestive of MSCC until spinal and neurological stability are ensured

Treatment of spinal metastases and MSCC: 2

Start definitive treatment, if appropriate, before any further

neurological deterioration and ideally within 24 hours of

the confirmed diagnosis of MSCC

Carefully plan surgery to maximise the probability

of preserving spinal cord function without undue

risk to the patient, taking into account their

overall fitness, prognosis and preferences

Treatment of spinal metastases and MSCC: 3

Treatment of spinal metastases and MSCC: 4

Ensure urgent (within 24 hours) access to and

availability of radiotherapy and simulator facilities in

daytime sessions, 7 days a week, for patients with

MSCC requiring definitive treatment or who are

unsuitable for surgery

Supportive care and rehabilitation

Start discharge planning and

ongoing care including

rehabilitation on admission

Costs and savingsEstimated cases per year in England: 3,100

Recommendations with significant costs

Estimated annual incremental costs resulting from increase in surgical activity(£000s per year)

Surgery for treatment and prevention of MSCC14,023

Recommendations with significant savingsSavings (£000s per year)

Supportive care and rehabilitation post discharge of patients

-17,513

Net resource impact of MSCC guideline -3,490

Costs correct at Nov. 2008 Costs not updated for 2nd. edition

Costs and savings

Recommendations that may result in additional costs depending on local circumstances:

• Early diagnosis: improving access to MRI scanning services

• Treatment: increasing number of surgical procedures

Recommendations that may result in additional savings include preventing late crisis intervention or need for supportive care

Discussion• How can cancer networks coordinate and audit the pathway?

• How do we ensure 24-hour availability of senior clinical advisers in centres treating patients with MSCC?

• How do we ensure 24-hour provision of the role of MSCC coordinator?

• How do we raise primary care awareness of significant symptoms?

• How can we improve timeliness of referral and imaging?

• What is the current provision of community-based rehabilitation and supportive care services and do we need to improve this?

Find out more

Visit www.nice.org.uk/CG75 for:

•the NICE guideline •‘Understanding NICE guidance’•local patient information template•implementation advice•costing report and template•audit support

What do you think?

Did the implementation tool you accessed today meet your requirements, and will it help you to put the NICE guidance into practice?

We value your opinion and are looking for ways to improve our tools. Please complete a short evaluation form by clicking here.

If you are experiencing problems accessing or using this tool, please email implementation@nice.org.uk

To open the links in this slide – right click over the link and choose ‘open hyperlink’.

NB. Not part of presentation